The cerebrospinal fluid biomarker ratio A[beta]42/40 identifies amyloid positron emission tomography positivity better than A[beta]42 alone in a heterogeneous memory clinic cohort

Background Cerebrospinal fluid (CSF) analysis for detecting amyloid positivity may be as reliable as positron emission tomography (PET). We evaluated the performance of the amyloid beta (A[beta])42/40 ratio for predicting amyloid positivity by PET, compared with A[beta]42 alone, and phosphorylated t...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Alzheimer's research & therapy 2022-04, Vol.14 (1)
Hauptverfasser:	Amft, Michaela, Ortner, Marion, Eichenlaub, Udo, Goldhardt, Oliver, Diehl-Schmid, Janine, Hedderich, Dennis M, Yakushev, Igor, Grimmer, Timo
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer's disease Amyloid beta-protein Biological markers Diagnosis Health aspects Identification and classification Puncture Spine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!